SAN DIEGO, CA---September 21, 2006---DexCom, Inc. (NASDAQ:DXCM) today announced that Andy Rasdal, Chief Executive Officer, will present an update on DexCom at the UBS Global Life Sciences Conference in New York on Tuesday, September 26, at 7:30 AM ET. The presentation, which will occur live at the Grand Hyatt New York, will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com under the investor webcast section and will be archived for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for people with diabetes.
FOR MORE INFORMATION:
Chief Financial Officer